REGISTERED NUMBER: 08805095 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 March 2026

for

Hardy Medical Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

Dr R Hardy

Mrs M Hardy

REGISTERED OFFICE:

Lennox House

3 Pierrepont Street

Bath

BA1 1LB

REGISTERED NUMBER:

08805095 (England and Wales)

FIXED ASSETS

Tangible assets

4

1,201

1,601

CURRENT ASSETS

Debtors

5

11,181

13,991

Cash at bank

95,376

83,565

106,557

97,556

CREDITORS

Amounts falling due within one year

6

21,912

44,241

NET CURRENT ASSETS

84,645

53,315

TOTAL ASSETS LESS CURRENT LIABILITIES

85,846

54,916

CAPITAL AND RESERVES

Called up share capital

10

10

Retained earnings

85,836

54,906

SHAREHOLDERS' FUNDS

85,846

54,916

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 September 2026 and were signed on its behalf by:

Mrs M Hardy - Director

1.	STATUTORY INFORMATION

Hardy Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

-

25% on reducing balance

Computer equipment

-

25% on reducing balance

Financial instruments

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2025 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

Computer

machinery

equipment

Totals

£

£

£

COST

At 1 April 2025

and 31 March 2026

2,882

1,761

4,643

DEPRECIATION

At 1 April 2025

1,845

1,197

3,042

Charge for year

259

141

400

At 31 March 2026

2,104

1,338

3,442

NET BOOK VALUE

At 31 March 2026

778

423

1,201

At 31 March 2025

1,037

564

1,601

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2026

2025

£

£

Trade debtors

11,181

13,991

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2026

2025

£

£

Tax

17,677

13,221

Directors' current accounts

3,735

30,520

Accruals and deferred income

500

500

21,912

44,241

7.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

Included within Other Creditors is £3,735 (2025 £30,520), which is owed by the company to Dr R Hardy, a director of the company. The loan is not interesting bearing nor will it be repaid to the detriment of the company.

8.	ULTIMATE CONTROLLING PARTY

The controlling party is Dr R Hardy.